FTRP News and Press, Field Trip Health Ltd. From 07/14/22

The psychedelics industry today has focused mostly on finding, patenting, and taking to clinical trials some version of a psychedelic substance. But now that these substances are going deeper into clinical trials than ever before, the goals that researchers are working to ac...

Field Trip Health Ltd. (FTRP) Q4 2022 Earnings Conference Call June 30, 2022 08:30 ET Company Participants Kathleen Heaney - Investor Relations Joseph Del Moral - Co-Founder and Chief Executive Officer Ronan Levy - Co-Founder and Executive Chairman Donna Wong...

Field Trip Health Ltd. (NASDAQ: FTRP) reported fiscal fourth-quarter and full-year 2022 results for the period ending March 31, 2022, and provided a business update today. All results are reported in Canadian dollars. For the quarter, Field Trip earned patient services revenues of $...

Field Trip Health press release ( NASDAQ: FTRP ): Q4 GAAP EPS of -C$0.25. Revenue of C$1.72M (+224.5% Y/Y). As of March 31, 2022 Field Trip had unrestricted cash and cash equivalents and restricted cash of C$64.5M. For further details see: Field Trip Health G...

Completed strategic review and announced intention to separate the Field Trip Discovery and Field Trip Health divisions into two independent public companies. Earned patient services revenues of $1.7 million in fiscal fourth quarter, an increase of 26.7% over the prior quarter and...

Psychedelic therapies company Field Trip Health ( NASDAQ: FTRP ) said it has received final court approval for the spin-out of its clinics business to Field Trip Health & Wellness. The spin-out is to be executed by way of a plan of arrangement, with the closi...

- Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange. - Closing of the arrangement expected to occur in August. - Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 (GLOB...

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip" or "Corporation"), a global leader in the development and delivery of psychedelic therapies, today announced that on June 27, 2022, its shareholders approved both the Arrangeme...

TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that Field Trip’s Co-founder and Executive Chairman, Ronan Levy, and Chief Sc...

TORONTO, June 22, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, announced today that it plans to release financial results for its fiscal fourth quarter and full ye...